An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00440817|
Recruitment Status : Completed
First Posted : February 27, 2007
Last Update Posted : April 10, 2014
|Condition or disease||Intervention/treatment||Phase|
|Lymphoma||Other: No intervention||Phase 4|
|Study Type :||Observational|
|Actual Enrollment :||120 participants|
|Official Title:||A Review of Reports of Lymphoma Occurring in Patients With Rheumatoid Arthritis or Crohn's Disease in Centocor-Sponsored and Centocor-Supported Disease Registries|
|Study Start Date :||February 2006|
|Primary Completion Date :||August 2006|
|Study Completion Date :||August 2006|
U.S. FDA Resources
Patients with lymphoma
Lymphoma Occurring in Patients with Rheumatoid Arthritis or Crohn's Disease
Other: No intervention
All treatments are prescribed by a physician on the basis of usual clinical practice.
- Occurrence of lymphoma [ Time Frame: 5 years ]To examine the occurrence of lymphoma among patients in one Centocor-sponsored and Centocor-supported disease registries
- Assessment of lymphoma risk [ Time Frame: 5 years ]To assess lymphoma risk in relevant registry patient populations, including patients not receiving anti-TNF therapies, patients receiving conventional immunosuppressants (including corticosteroids), and patients receiving anti-TNF therapies
- Evaluation of association of Epstein-Barr Virus (EBV) with the lymphoma [ Time Frame: 5 years ]To evaluate all available data on tissue samples of individual lymphoma cases for the potential association of EBV with the lymphoma.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00440817
|United States, Illinois|
|Highland Park, Illinois, United States|
|United States, Kansas|
|Wichita, Kansas, United States|
|United States, New York|
|Albany, New York, United States|
|Study Director:||Centocor Ortho Biotech Services, L.L.C. Clinical Trial||Centocor Ortho Biotech Services, L.L.C.|